NTRK1 and neoplasm: All NTRK-rearranged neoplasms are characterized by immunohistochemical positivity for CD34 and S100 and, molecularly, by fusions of NTRK1, NTRK2, and NTRK3 genes with variable partners; alternative RAF1 and BRAF fusions have also been described.